Feature Healthcare Stocks Top News A Close Look at Cardiol Therapeutics’ Phase 2 Results Shows the Path Forward Not all clinical trial results are cut and dried. Sometimes the outcome… Robin LeffertsDecember 9, 2025
Feature Healthcare Stocks Top News Investor Opportunity: Big Pharma Patent Cliff Spurring Surge in M&A Activity Here’s the short version: Big pharma is staring down a real patent… Robin LeffertsNovember 18, 2025
Feature Healthcare Stocks Top News Cardiol Therapeutics’ Financing Paves Way for Heart Failure Drug Development Smaller pharmaceutical companies embark on an exciting journey as they seek to… Robin LeffertsOctober 29, 2025
Feature Healthcare Stocks Top News Phase II Results Point the Way Forward for Cardiol Therapeutics For smaller public company drug developers clinical trial results are major catalytic… Robin LeffertsSeptember 16, 2025
Feature Healthcare Stocks Understanding the Importance of Left Ventricular Mass in Heart Conditions Left ventricular (LV) mass has emerged as one of the most powerful… Robin LeffertsSeptember 15, 2025
Feature Healthcare Stocks Top News Cardiol Therapeutics Announces Topline Results from the Phase II ARCHER Trial of CardiolRx™ in Acute Myocarditis Toronto, Ontario–(Newsfile Corp. – August 6, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)… Ryan AllwayAugust 6, 2025
Feature Healthcare Stocks Former Eli Lilly CMO Joins Cardiol’s Board, Bolstering Drug Development, Clinical Trial, and Commercial Expertise As smaller clinical stage pharmaceutical companies advance drug candidates from the lab… Robin LeffertsMay 29, 2025
Healthcare Stocks Cardiol Therapeutics Nominates Dr. Timothy Garnett to Its Board of Directors Former Chief Medical Officer of Eli Lilly brings more than thirty years… Ryan AllwayApril 29, 2025
Feature Healthcare Stocks The Growing Market for Recurrent Pericarditis Therapies Recurrent pericarditis management has evolved significantly in recent years, with treatment approaches… Robin LeffertsApril 16, 2025
Healthcare Stocks Cardiol Therapeutics Enrolls First Patient in Pivotal Phase III MAVERIC Trial in Recurrent Pericarditis Toronto, Ontario–(Newsfile Corp. – April 16, 2025) – Cardiol Therapeutics Inc. (NASDAQ: CRDL)… Ryan AllwayApril 16, 2025
